Other Benefits of Ertugliflozin
During the two trials, named the VERTIS MET and VERTIS SITA, Ertugliflozin has been shown to improve and control blood sugar levels in participants. Furthermore, it has also been shown to help meet its primary outcomes. VERTIS MET, the first study, lasted for 26 weeks. The study evaluates the safety and effectiveness of the 15 mg and 5 mg Ertugliflozin. During the study, the medication was combined with other medications, such as metformin. It was also compared to placebo and metformin in about 464 adults. These patients have poorly controlled Type 2 diabetes and were just taking the metformin.
Patients who were taking the Ertugliflozin combination have shown lower HbA1c levels and lower blood sugar levels. They have also lost more weight and have shown to have much lower blood pressure levels.
